Transcript: Michael Rockefeller
Barry Ritholtz
DECEMBER 19, 2023
They run long short across each of these, and they’ve put up some pretty impressive numbers over the past couple of years. 00:04:29 [Speaker Changed] So you start at the healthcare group as an analyst in Citi in the early two thousands, obviously the background in neuro had to help. It’s beta neutral, market neutral.
Let's personalize your content